Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma

16 Apr 2018

Abstract excerpt

Uterine leiomyosarcoma (u-LMS) and endometrial stromal sarcoma (ESS) are among the most frequent soft tissue sarcomas, which, in adults, lead to fatal lung metastases and patients have an extremely poor prognosis. Due to their rarity and heterogeneity, there are no suitable biomarkers for diagnosis and prognosis, although some biomarker candidates have appeared. In 2017, The Cancer Genome Atlas (TCGA) Research...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Endometrial and Cervical Cancer Treatments
Share to Sarcoma Diagnosis and Treatment
Share to Uterine Myomas and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29660202
DOI: 10.1111/cas.13613

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcomaPMID 29660202Read ↗

Endometrial stromal sarcoma – the new genetic paradigmSemantic proximity Read ↗

Molecular Classification of Endometrial Stromal Sarcomas Using RNA Sequencing Defines Nosological and Prognostic Subgroups with Different Natural HistorySemantic proximity Read ↗

Targeted RNA Sequencing Highlights a Diverse Genomic and Morphologic Landscape in Low-grade Endometrial Stromal Sarcoma, Including Novel Fusion GenesSemantic proximity Read ↗

Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12Semantic proximity Read ↗

Endometrial stromal tumors: the new WHO classification.Semantic proximity Read ↗

Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays.Semantic proximity Read ↗

JAZF1/SUZ12 gene fusion in endometrial stromal sarcomasSemantic proximity Read ↗

Immunohistochemical and Molecular Characterization of Endometrial Stromal SarcomasSemantic proximity Read ↗

Genomic and Transcriptomic Characterization Revealed the High Sensitivity of Targeted Therapy and Immunotherapy in a Subset of Endometrial Stromal SarcomaSemantic proximity Read ↗

Interrogating the Genomic Landscape of Uterine Leiomyosarcoma: A Potential for Patient BenefitSemantic proximity Read ↗

Uterine carcinosarcoma: Contemporary clinical summary, molecular updates, and future research opportunity.Semantic proximity Read ↗

Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.